Dr. Camila de Almeida joined Certara as Associate Director of Consulting Services in January 2018. With an interdisciplinary background in biology and physics, she received a PhD in Systems Biology from the University of Aberdeen, on “Modeling of the protection mechanisms against methylglyoxal stress in Escherichia coli.” Due to her interest in mechanistic modeling and drug discovery, she moved to the oncology therapeutic area where she acquired over 8 years’ experience in developing translational PKPD models from pre-clinical species to the clinic. She has expertise across the whole drug development process.
Her initial focus was on early stage drug discovery, working closely with clients on the design of modeling-focused pre-clinical PKPD studies, building mechanistically relevant PK/PD models and identifying the PK requirements for efficacy. She also has extensive experience in providing human dose and schedule predictions based on the pre-clinical modeling. After joining Certara, Dr. de Almeida has supported early stage biologics projects in the immunotherapy area, and consolidated her expertise in late stage development by providing population PK analysis of clinical data.